Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Recommendation of “Moderate Buy” by Analysts
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has received an average rating of “Moderate Buy” from the nineteen ratings firms that are covering the firm, Marketbeat.com reports. Eight research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price objective […]
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has received an average rating of “Moderate Buy” from the nineteen ratings firms that are covering the firm, Marketbeat.com reports. Eight research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price objective […]
